Mitra Tavakoli

So proud of this huge collaboration project ! This wasn’t possible without the effort and contribution of all wonderful colleagues across the world!

"Language about rare disease is a powerful—but underused—lever for change." In a new Comment, authors call for a profound shift in how health-care providers use language within the rare disease ecosystem. Find out more in our latest issue: spkl.io/6014AF8e6

My favourite academia joke of all time. "The moral of this story is: The topic of your dissertation isn't really important; what's important is who your advisor is." —Harvey Cox, When Jesus Came to Harvard

"Science is really a process of seeking the truth." Our newest medicine laureate Mary Brunkow on the joy of science and what she loves about research. Brunkow was awarded the 2025 medicine prize for discoveries concerning peripheral immune tolerance. #WomenInScience

@theendeavorpath Workbook

10 Things to Do Before 2025 Ends. -Thread-

In May 1921, Fredrick Banting met his research assistant Charles Best in John Macleod's lab to begin their experiments with insulin. In January 1922, the first person received an insulin injection. By 1923, insulin was commercially available. Banting and Macleod received the 1923 Nobel Prize in Physiology or Medicine. #WorldDiabetesDay

Be worry …

Radical open-mindedness and radical transparency are invaluable for rapid learning and effective change. Learning is the product of a continuous real-time feedback loop in which we make decisions, see their outcomes, and improve our understanding of reality as a result. Being radically open-minded enhances the efficiency of those feedback loops, because it makes what you are doing, and why, so clear to yourself and others that there can’t be any misunderstandings. The more open-minded you are, the less likely you are to deceive yourself— and the more likely it is that others will give you honest feedback. If they are “believable” people (and it’s very important to know who is “believable”), you will learn a lot from them. #principleoftheday

An electronic eye implant has restored vision in people with blindness caused by age-related macular degeneration go.nature.com/3JnPu5n

Join us tomorrow at the @exeternihr Open Evening! Meet the team, explore exciting research, and find out how you can get involved. No booking needed! ow.ly/JZ6850X1sHj #NHSResearch #ClinicalTrials #Exeter

"Follow your passions. If you keep the passion to answer the question, you'll do very well." Get some valuable career advice from our 2023 Nobel Prize laureates Katalin Karikó, Claudia Goldin and Anne L'Huillier.

🔥Hot of the Press 11 Sept ‘25🔥 FREE ACCESS: pmc.ncbi.nlm.nih.gov/articles/PMC12… Proud member of @DiabetesTechSoc’ global team to explore, how machine learning is being used to diagnose, detect and predict complications of diabetes. Our benchmarking global review is now out. #StenoNord

@EvaFeldmanMDPhD @peteratmsr Dear Eva, I was really sad to miss this important webinar as it coincided with Neurodiab events. Is a recording available? We truly missed your insight and perspective this year.

I had a great time sitting down with @peteratmsr to discuss "AI & the Future of Medicine" yesterday.

Today the start of the 35th Annual Meeting of NEUROdiab 11-14 September 2025, Bucharest, Romania #NEUROdiab2025 2025.neurodiab.org We look forward to welcoming you to Bucharest

The Priority Review Voucher program has delivered lifesaving treatments for children who once had none. Congress must reauthorize it now to ignite U.S. innovation and ensure children don’t lose access to cures – and hope. Learn more: bio.org/prv

What a fun project to edit! Out in print this month (@ANA_journals), I definitely recommend you read all three parts. AI in Neurology: Everything, Everywhere, All at Once Part 1: Principles and Practice - Rizzo - 2025 onlinelibrary.wiley.com/doi/10.1002/an…

I would like to share the story of how a patient with cancer came up with the idea for a randomized trial, & how listening to him saved a lot of lives. 1/ In 2002, I had just completed a randomized trial with the notorious drug thalidomide for the cancer, multiple myeloma.

Congratulations to our ophthalmology team on being shortlisted as a finalist in the 2025 HSJ Awards. The team developed the See-and-Treat Immediate Sequential Bilateral Cataract Surgery (S&T ISBCS) pathway, allowing suitable patients to have both eyes treated in a single visit.

Dr. Peter J. Dyck passed away peacefully surrounded by family on 07/26/25 at the age of 97. We will honor his legacy and keep him alive through our research, teachings, and patient care. Rest in peace and thank you for everything, Peter! @MayoClinicNeuro

@Neurodiab_eu @MarcusVPinto @MayoClinicNeuro @EASDnews @NielsEjskjaer @VinceSpallone @EvaFeldmanMDPhD @PNSociety1 @GordonSloan9 @PrashVas @KenderZoltan @EidSteph An extraordinary and exceptionally talented scientist, who in my opinion has contributed the most in the field of diabetic neuropathies through a lifetime of deciplined, high qualty body of work! RIP Prof.

@RoshanaMN Congratulations Roshana

20 years of training 1 marriage 👰🏽‍♀️🤵🏻 2 children 👦🏽👦🏽 12 Hospitals 🏥 16 exams 📈 5 city moves 2000 operations+ 🛠️ Many tears Convincing myself not to quit Fighting for my & other rights Today Completion of training early CCT ✅😭: Trauma and Orthopaedic Surgery